A device is seeking US market approval while the company adopts International Financial Reporting Standards (IFRS) set by the IASB.
1 report, 1 independent
Updated May 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A device is seeking US market approval while the company adopts International Financial Reporting Standards (IFRS) set by the IASB.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- ASE received certification meeting high standards for the US market.Sub-event
- Guanajuato Silver Company operates in Guanajuato while preparing financial statements in accordance with IFRS standards.Sub-event
Device seeks FDA approval while company adopts IASB standards.1 source
Keep exploring
The entities involved
- FDA
-
International Accounting Standards Board
the body in IFRS Foundation which develops IFRS
Nothing else this week.
Related events
- FDA clearance enables market entry into the U.S. for an unnamed company, which is also navigating the long-term regulatory process in Japan.
- The FDA operates under US law to evaluate international clinical data.
- FDA clearance drives market expansion and coverage for NeurAxis, Inc.
- Unicycive Therapeutics, Inc. is facing investigator findings regarding manufacturing compliance issues from the FDA.
- Congress considered proposals to strengthen FDA authority regarding medical device regulation and minimum standards.